首页|天智颗粒联合多奈哌齐对卒中后认知功能障碍患者认知功能及血清神经递质水平的影响

天智颗粒联合多奈哌齐对卒中后认知功能障碍患者认知功能及血清神经递质水平的影响

扫码查看
目的 研究天智颗粒联合多奈哌齐对卒中后认知功能障碍(PSCI)患者认知功能及血清神经递质水平的影响。方法 回顾性选取 2021 年 1 月至 2023 年 6 月南阳南石医院收治的 90 例PSCI患者为研究对象,按照治疗方案分为对照组、联合组,各 45 例。对照组采用多奈哌齐治疗,联合组采用天智颗粒联合多奈哌齐治疗。比较两组临床疗效,治疗前后中医证候积分,Barthel指数(BI)评分,美国国立卫生研究院卒中量表(NIHSS)评分,蒙特利尔认知评估量表(MoCA)评分,脑动脉[大脑前动脉(ACA)、大脑中动脉(MCA)、大脑后动脉(PCA)]血流速度,血清神经递质[神经元特异性烯醇化酶(NSE)、去甲肾上腺素(NE)、脑源性神经营养因子(BDNF)、神经元PAS结构域蛋白4(NPAS4)]水平,不良反应发生率。结果 联合组临床总有效率(95。56%)高于对照组(82。22%)(P<0。05)。治疗3 个月后,联合组中医证候积分、NIHSS评分低于对照组,BI、MoCA评分高于对照组(P<0。05);联合组ACA、MCA、PCA血流速度大于对照组(P<0。05);联合组血清NSE、NPAS4 水平低于对照组,NE、BDNF水平高于对照组(P<0。05)。联合组不良反应总发生率(13。33%)与对照组(8。89%)相比,差异无统计学意义(P>0。05)。结论 采用天智颗粒与多奈哌齐联合治疗PSCI患者有利于促进神经功能、认知功能、日常生活能力改善,可提高脑动脉血流,增强疗效,安全性良好。
Effects of Tianzhi Granules Combined with Donepezil on Cognitive Function and Serum Neurotransmitter Levels in Patients with Post-stroke Cognitive Impairment
Objective To study the effects of tianzhi granules combined with donepezil on cognitive function and serum neurotransmitter levels in patients with post-stroke cognitive impairment(PSCI).Methods A total of 90 patients with PSCI admitted to Nanyang Nanshi Hospital from January 2021 to June 2023 were retrospectively selected as the study objects,and were divided into control group and combined group according to the treatment plan,with 45 cases in each group.The control group was treated with donepezil,and the combined group was treated with tianzhi granules combined with donepezil.Compare the clinical efficacy of the two groups,as well as Barthel index(BI),National Institutes of Health Stroke Scale(NIHSS),Montreal Cognitive Assessment Scale(MoCA)score,cerebral artery[Arteriae cerebri anterior(ACA),middle cerebral artery(MCA),posterior cerebral artery(PCA)]blood flow velocity,serum neurotransmitters[Neuron-specific enolase(NSE),norepinephrine(NE),brain-derived neurotrophic factor(BDNF),neuronal PAS domain protein 4(NPAS4)]levels,incidence of adverse reactions before and after treatment.Results The total effective rate of combined group(95.56%)was higher than that of control group(82.22%)(P<0.05).After 3 months of treatment,NIHSS scores in combined group were lower than those in control group,BI and MoCA scores were higher than those in control group(P<0.05);the blood flow velocity of ACA,MCA and PCA in combined group were higher than those in control group(P<0.05);the serum levels of NSE and NPAS4 in combined group were lower than those in control group,and the levels of NE and BDNF were higher than those in control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between two groups(P>0.05).Conclusion The combination of tianzhi granules and donepezil in the treatment of PSCI patients can promote the improvement of nerve function,cognitive function and daily living ability,improve cerebral artery blood flow,enhance the efficacy and safety.

StrokeCognitive dysfunctionTianzhi granulesDonepezilNeurotransmitter

苏子龙、黄玉伟

展开 >

南阳南石医院,河南 南阳 473000

卒中 认知功能障碍 天智颗粒 多奈哌齐 神经递质

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(3)